ORTHO
Desconocido
ActiTOX: Active organotypic models for nanoparticle toxicological screening
ORTHOSERA GMBH
participó en un
H2020:
H2020-MSCA-RISE-2018
Nanoparticles and new drugs are undergoing complex toxicity evaluation prior to their use in products for customers.
However, the traditiona...
2019-06-13 - 2024-07-31 | Financiado
2019-06-13 - 2024-07-31 | Financiado
iP-OSTEO: Induced pluripotent stem cell seeded active osteochondral nanofibrous scaffolds
ORTHOSERA GMBH
participó en un
H2020:
H2020-MSCA-RISE-2018
IP-OSTEO project focuses on development of novel cell-based scaffolds for bone and cartilage repair in patients with poor regenerative capac...
2018-11-14 - 2024-07-31 | Financiado
2018-11-14 - 2024-07-31 | Financiado
* No se disponen de datos de la empresa actual.